Clinical Trial Update: Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of Telintra in chemotherapy-induced neutropenia for non-small cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Telintra

Snippet

Sponsor: Telik | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: TERMINATED